Profiles of cytokine mRNAs in the skin and lymph nodes of SENCAR mice treated epicutaneously with dibenzo[a,l]pyrene or dimethylbenz[a]anthracene reveal a direct correlation between carcinogen-induced contact hypersensitivity and epidermal hyperplasia

Molecular Carcinogenesis

Volumn 27, Issue 2, 2000, Pages 125-140

  Casale, George P ^a   Cheng, Zhao ^a   Liu, Jia Nuo ^a   Cavalieri, Ercole L ^a   Singhal, Maria ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Carcinogenesis; Cytokine; Hyperplasia; Hypersensitivity; Promotion

Indexed keywords

CYTOKINE; DIBENZO[A,L]PYRENE; DIMETHYLBENZ[A]ANTHRACENE; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CARCINOGENICITY; CONTACT ALLERGY; CONTROLLED STUDY; DNA SYNTHESIS; EPIDERMIS HYPERPLASIA; HYPERSENSITIVITY; INFLAMMATION; LYMPH NODE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR PROMOTION;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ADMINISTRATION, CUTANEOUS; ANIMALS; BENZOPYRENES; CARCINOGENS; CYTOKINES; DERMATITIS, CONTACT; EPIDERMIS; FEMALE; HYPERPLASIA; LYMPH NODES; MICE; MICE, INBRED SENCAR; RNA, MESSENGER; SKIN;

ANIMALIA;

EID: 0033950304     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(200002)27:2<125::AID-MC8>3.0.CO;2-0     Document Type: Article

References (40)

1. Pitot HC. Stages in neoplastic development. In: Schottenfeld D, Fraumeni JF, editors. Cancer epidemiology and prevention. New York: Oxford. 1996; p 65-79.
2. Grimmer G. Environmental carcinogens: Polycyclic aromatic hydrocarbons. Boca Raton: CRC Press, 1983.
3. Mumford JL, Li X, Hu F, Lu XB, Chuang JC. Human exposure and dosimetry of polycyclic aromatic hydrocarbons in urine from Xuan Wei, China with high lung cancer mortality associated with exposure to unvented coal smoke. Carcinogenesis 1995;16:3031-3036.
4. Chakravarti D, Pelling JC, Cavalieri EC, Rogan EG. Relating aromatic hydrocarbon-induced DNA adducts and c-H-ras mutations in mouse skin: The role of apurinic sites. Proc Natl Acad Sci USA 1995,92:10422-10426.
5. Chakravarti D, Mailander P, Franzen J, Higginbotham S, Cavalieri EL, Rogan EG. Detection of dibenzo[a,l]pyrene-induced H-ras codon 61 mutant genes in preneoplastic SENCAR mouse skin using a new PCR-RFLP method. Oncogene 1998;16:3203-3210.
6. DiGiovanni J. Multistage carcinogenesis in mouse skin. Pharmacol Ther 1992;54:63-128.
7. Albert RE, Miller ML, Cody T, Andringa A, Shukla R, Baxter CS. Benzo[a]pyrene-induced skin damage and tumor promotion in the mouse. Carcinogenesis 1991;12: 1273-1280.
8. Casale GP, Higginbotham S, Johansson SL, Rogan EG, Cavalien EC. Inflammatory response of mouse skin exposed to the very potent carcinogen dibenzo[a,l]pyrene: A model for tumor promotion. Fundam Appl Toxicol 1997;36: 71-78.
9. Dipple A, Pigott MA, Bigger CAH, Blake DN. 7,12-Dimethylbenz[a]anthracene-DNA binding in mouse skin: Response of different mouse strains and effects of various modifiers of carcinogenesis. Carcinogenesis 1984;5: 1087-1090.
10. Wei L, Wei H, Frenkel K. Sensitivity to tumor promotion of SENCAR and C57BL/6J mice correlates with oxidative events and DNA damage. Carcinogenesis 1993;14:841-847.
11. Frenkel K. Carcinogen-mediated oxidant formation and oxidative damage. Pharmacol Ther 1992;53:127-166.
12. Frenkel K, Wei L, Wei H, Karkoszka J. Polycyclic aromatic hydrocarbons (PAH) induce oxidative stress and oxidative DNA modification: Characteristics of tumor promotion. Polycyclic Aromatic Compounds 1994;6:151-160.
13. Fjelde A, Turk JL. Induction of an immunologic response in local lymph nodes by chemical carcinogens. Nature 1965; 205:813-815.
14. Klemme JC, Mukhtar H, Elmets CA. Induction of contact hypersensitivity to dimethylbenz(a)anthracene and benzo(a)pyrene in C3H/HeN mice. Cancer Res 1987;47: 6074-6078.
15. Ashby J, Hilton J, Dearman RJ, Callander RD, Kimber I. Mechanistic relationship among mutagenicity, skin sensitization, and skin carcinogenicity. Environ Health Perspect 1993,101:62-67.
16. Albert RE. Allergenic contact sensitizing chemicals as environmental carcinogens. Environ Health Perspect 1997; 105:940-948.
17. Cavalieri EC, Higginbotham S, RamaKrishna NVS, et al. Comparative dose-response tumorigenicity studies of dibenzo[a,l]pyrene versus 7,12-dimethylbenz[a]anthracene, benzo[a]pyrene, and two dibenzo[a,l]pyrene dihydrodiols in mouse skin and rat mammary gland. Carcinogenesis 1991; 12:1939-1944.
18. Higginbothan S, RamaKrishna NVS, Johansson SL, Rogan EG, Cavalieri EC. Tumor initiating activity and carcinogenicity of dibenzo[a,l]pyrene versus 7,12-dimethylbenz[a]anthracene and benzo[a]pyrene at low doses in mouse skin. Carcinogenesis 1993;14:875-878.
19. Bouloc A, Cavani A, Katz SI. Contact hypersensitivity in MHC class II-deficient mice depends on CD8 T lymphocytes primed by immunostimulating Langerhans cells. J Invest Dermatol 1998;111:44-49.
20. Xu H, Banerjee A, Dilulio NA, Fairchild RL. Development of effector CD8+ T cells in contact hypersensitivity occurs independently of CD4+ T cells. J Immunol 1997;158: 4721-4728.
21. Grabbe S, Schwarz T. Immunoregulatory mechanisms involved in elicitation of allergic contact hypersensitivity. Immunol Today 1998;19:37-44.
22. Gocinski BL, Tigelaar RE. Roles of CD4+ and CD8+ T cells in murine contact sensitivity revealed by in vivo monoclonal antibody depletion. J Immunol 1990;144: 4121-4128.
23. Xu H, Dilulio NA, Fairchild RL. T cell populations primed by hapten sensitization in contact hypersensitivity are distinguished by polarized patterns of cytokine production: Interferon γ-producing (Tc1) effector CD8+ T cells and interleukin (II) 4/II-10-producing (Th2) negative regulatory CD4-Tcells. J Exp Med 1996;183:1001-1012.
24. Enk AH, Katz SI. Early molecular events in the induction phase of contact sensitivity. Proc Natl Acad Sci USA 1992;89:1398-1402.
25. Enk AH, Angeloni VL, Udey MC, Katz SI. An essential role for Langerhans cell-derived IL-1β in the initiation of primary immune responses in skin. J Immunol 1993;150: 3698-3704.
26. Luger TA, Schwarz T. Evidence for an epidermal cytokine network. J Invest Dermatol 1990;95:100s-104s.
27. Schwarzenberger K, Udey MC. Contact allergens and epidermal proinflammatory cytokines modulate Langerhans cell E-cadherin expression in situ. J Invest Dermatol 1996; 106:553-558.
28. Enk AH, Angeloni VL, Udey MC, Katz SI. Inhibition of Langerhans cell antigen-presenting function by IL-10. J Immunol 1993;151:2390-2398.
29. Thomson JA, Troutt AB, Kelso A. Contact sensitization to oxazolone: involvement of both interferon-γ and interleukin-4 in oxazolone-specific Ig and T-cell responses. Immunol 1993;78:185-192.
30. Asada H, Linton J, Katz SI. Cytokine gene expression during the elicitation phase of contact sensitivity: Regulation by endogenous IL-4. J Invest Dermatol 1997;108:406-411.
31. Piguet PF, Grau GE, Hauser C, Vassalli P. Tumor necrosis factor is a critical mediator in hapten-mduced irritant and contact hypersensitivity reactions. J Exp Med 1991;173: 673-679.
32. NIH Publication No. 81-2385. NIH guidelines for the laboratory use of chemical carcinogens. Washington: U.S. Government Printing Office, 1981.
33. Tamaki K, Stingl G, Gullino M, Sachs DH, Katz SI. Ia antigens in mouse skin are predominantly expressed on Langerhans cells. J Immunol 1979;123:784-787.
34. Morikawa Y, Tohya K, Ishida H, Matsuura N, Kakudo K. Different migration patterns of antigen-presenting cells correlate with Th1/Th2-type responses in mice. Immunol 1995;85:575-581.
35. Zhou H, Yan D, Pestka JJ. Differential cytokine mRNA expression in mice after oral exposure to the trichothecene vomitoxin (deoxynivalenol): Dose response and time course. Toxicol Appl Pharmacol 1997;144:294-305.
36. Maeda A, Hiyama K, Yamakido H, Ishioka S, Yamakido M. Increased expression of platelet-derived growth factor A and insulin-like growth factor-I in BAL cells during the development of bleomycin-induced pulmonary fibrosis in mice. Chest 1996;109:780-786.
37. Fujisawa H, Kondo S, Wang B, Shivji GM, Sauder DN. The role of CD4 molecules in the induction phase of contact hypersensitivity: cytokine profiles in the skin and lymph nodes. Immunol 1996;89:250-255.
38. Berg DJ, Leach MW, Kuhn R, et al. Interleukin 10 but not interleukin 4 is a natural suppressant of cutaneous inflammatory responses. J Exp Med 1995;182:99-108.
39. Ferguson TA, Dube P, Griffith TS. Regulation of contact hypersensitivity by interleukin 10. J Exp Med 1994;179: 1597-1604.
40. Enk AH, Katz SI. Contact sensitivity as a model for T-cell activation in skin. J Invest Dermatol 1995;105:80s-83s.